A form of autosomal dominant spondyloepiphyseal dysplasia is caused by a glycine to alanine substitution in the COL2A1 gene

2006 ◽  
Vol 15 (4) ◽  
pp. 197-202 ◽  
Author(s):  
Gabrielle S. Sellick ◽  
Kristein P. Hoornaert ◽  
Geert R. Mortier ◽  
Catherine King ◽  
Claire L. Dolling ◽  
...  
2018 ◽  
Vol 9 (5) ◽  
pp. 241-246 ◽  
Author(s):  
Eirini Dikaiakou ◽  
Elpis A. Vlachopapadopoulou ◽  
Emanouil Manolakos ◽  
Panagiotis Samelis ◽  
Rodanthi Margariti ◽  
...  

Genes ◽  
2022 ◽  
Vol 13 (1) ◽  
pp. 137
Author(s):  
Tatyana Markova ◽  
Vladimir Kenis ◽  
Evgeniy Melchenko ◽  
Darya Osipova ◽  
Tatyana Nagornova ◽  
...  

The significant variability in the clinical manifestations of COL2A1-associated skeletal dysplasias makes it necessary to conduct a clinical and genetic analysis of individual nosological variants, which will contribute to improving our understanding of the pathogenetic mechanisms and prognosis. We presented the clinical and genetic characteristics of 60 Russian pediatric patients with type II collagenopathies caused by previously described and newly identified variants in the COL2A1 gene. Diagnosis confirmation was carried out by new generation sequencing of the target panel with subsequent validation of the identified variants using automated Sanger sequencing. It has been shown that clinical forms of spondyloepiphyseal dysplasias predominate in childhood, both with more severe clinical manifestations (58%) and with unusual phenotypes of mild forms with normal growth (25%). However, Stickler syndrome, type I was less common (17%). In the COL2A1 gene, 28 novel variants were identified, and a total of 63% of the variants were found in the triple helix region resulted in glycine substitution in Gly-XY repeats, which were identified in patients with clinical manifestations of congenital spondyloepiphyseal dysplasia with varying severity, and were not found in Stickler syndrome, type I and Kniest dysplasia. In the C-propeptide region, five novel variants leading to the development of unusual phenotypes of spondyloepiphyseal dysplasia have been identified.


2012 ◽  
pp. 127-153 ◽  
Author(s):  
Jürgen W. Spranger ◽  
Paula W. Brill ◽  
Gen Nishimura ◽  
Andrea Superti-Furga ◽  
Sheila Unger

Chapter 24 covers disorders of the Type 2 collegen group (achondrogenesis type 2 (MIM100610), hypochondrogenesis (MIM 200610), spondyloepiphyseal dysplasia Torrance type (MIM 151210), spondyloepiphyseal dysplasia congenita (MIM 183900), Kniest dysplasia (MIM 256550), spondyloperipheral dysplasia (MIM 271700), spondyloepiphyseal dysplasia with metatarsal shortening (MIM 609162), autosomal dominant spondyloarthropathy (MIM 604864), vitreoretinopathy with phalangeal epiphyseal dysplasia (MIM 120140.0037), Stickler dysplasia (MIM 108300, 604841)), including major clinical findings, radiographic features, and differential diagnoses.


2007 ◽  
Vol 382 (1-2) ◽  
pp. 148-150 ◽  
Author(s):  
Xinyi Xia ◽  
Yingxia Cui ◽  
Yufeng Huang ◽  
Lianjun Pan ◽  
Yongming Wu ◽  
...  

2003 ◽  
Vol 18 (9) ◽  
pp. 1612-1621 ◽  
Author(s):  
Leah Rae Donahue ◽  
BO Chang ◽  
Subburaman Mohan ◽  
Nao Miyakoshi ◽  
Jon E Wergedal ◽  
...  

2018 ◽  
pp. 135-156
Author(s):  
Jürgen W. Spranger ◽  
Paula W. Brill ◽  
Christine Hall ◽  
Gen Nishimura ◽  
Andrea Superti-Furga ◽  
...  

This chapter discusses metatropic dysplasia and other TRPV4-related skeletal dysplasias, including spondyloepiphyseal dysplasia (Maroteaux type), spondylometaphyseal dysplasia (Kozlowski type), brachyolmia (autosomal dominant), and familial digital arthropathy with brachydactyly. Each discussion includes major radiographic features, major clinical findings, genetics, major differential diagnoses, and a bibliography.


PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0127529 ◽  
Author(s):  
Xiangjun Huang ◽  
Xiong Deng ◽  
Hongbo Xu ◽  
Song Wu ◽  
Lamei Yuan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document